Researcher profile
Alan S. Green, MD
The weekly 6 mg protocol that dominates off-label rapamycin use came out of his clinic, not out of a trial. Anyone taking rapamycin on that schedule is following a convention he set.
- Role
- The first physician to run an off-label rapamycin longevity practice
- Affiliation
- his own private practice in New York; he is a board-certified pathologist
- Topics
- Rapamycin · Dosing · Off-label practice
- Died
- 2024
- Their work
- Search PubMed
Why we quote Green
The weekly 6 mg protocol that dominates off-label rapamycin use came out of his clinic, not out of a trial. Anyone taking rapamycin on that schedule is following a convention he set.
Alan S. Green, MD is one of the researchers quoted here; the others quoted alongside Alan are listed with the same disclosures.
Where they stand, and who pays
A practicing clinician describing case experience across more than 1,000 patients (per Green's own account), which is real information and is not a controlled trial, and this site does not treat it as one.
Stating this next to the quote rather than at the bottom of a disclosures page is the whole point. A concession made against a commercial interest is stronger evidence than a neutral summary; a claim made in line with one is weaker. You cannot weigh either without knowing which you are reading.
Everything we quote them saying
The one line, verbatim, in the order they appear in the site's citation index. Each one links to the recording and to the page it is used on.
Nobody is going to spend 200 million dollars to do a clinical study on a drug if it's not their drug.
Pages this research informs
Each page below cites this researcher directly, so you can see the claim a quote supports in its full context.
The standing disclaimer
Alan S. Green, MD has no relationship with Rapamycin.store and did not endorse anything on it.
- They have not reviewed this site or any page that quotes them.
- Quotes are used under fair dealing for criticism and review, each linked to its public recording so you can hear the full context.
- If a quote here misrepresents what was said, tell us and we will correct it. That correction goes to the front of the queue.
Researchers who want to set out a position in their own words, rather than be quoted, can send the editors a pitch.
References
3 sources, all link-checked; oldest check
- Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. International Committee of Medical Journal Editors, updated 2025.The conflict-of-interest and authorship conventions this desk follows for a lay publication.Verified Sep 14, 2026
- PubMed. US National Library of Medicine, National Institutes of Health.The index every citation on this site is checked against before publication.Verified Sep 14, 2026
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Guyatt GH et al. BMJ 2008;336:924.The framework behind the strong / mixed / limited evidence grades used across this site.Verified Sep 14, 2026
Every link above is re-requested on a schedule by an automated checker; the date shown is when it last answered. Publishers that block automated requests are marked as such rather than reported broken. Our editorial standards explain how a source gets cited here in the first place.
Filed by the Rapamycin.store evidence desk. Each source is re-checked when the page is reviewed.
Own a longevity or health brand?
Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.